Alterity Therapeutics
ATHE
12 hedge funds and large institutions have $1.45M invested in Alterity Therapeutics in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
9% more funds holding
Funds holding: 11 → 12 (+1)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
3% less capital invested
Capital invested by funds: $1.48M → $1.45M (-$37.9K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$118K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$110K |
| 3 |
Morgan Stanley
New York
|
+$77.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$249K |
| 2 |
Renaissance Technologies
New York
|
-$163K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3.12K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $904K | +$77.2K | +4,581 | +8% |
|
|
2
Renaissance Technologies
New York
| $324K | -$163K | -9,681 | -30% |
|
|
VF
3
Virtu Financial
New York
| $101K | +$118K | +6,991 | New |
|
|
4
Citadel Advisors
Miami,
Florida
| $94K | +$110K | +6,501 | New |
|
5
Geode Capital Management
Boston,
Massachusetts
| $17K | – | – | – |
|
6
Wells Fargo
San Francisco,
California
| $4K | – | – | – |
|
|
GWM
7
Geneos Wealth Management
Englewood,
Colorado
| $1K | – | – | – |
|
|
APA
8
American Portfolios Advisors
Holbrook,
New York
| $120 | – | – | – |
|
|
SPIA
9
Steward Partners Investment Advisory
New York
| $88 | – | – | – |
|
|
SM
10
Sabby Management
Miami Beach,
Florida
| – | -$249K | -18,584 | Closed |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$3.12K | -185 | -96% |
|
ATHE Hedge Fund Activity: Q1 2021 in Review
12 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q1 2021, worth a combined $1.45M — down 2.6% from $1.48M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ATHE positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $118K. The largest seller was Sabby Management, exiting entirely with an estimated $249K sold.
- 12 institutional investors held Alterity Therapeutics (ATHE) as of Q1 2021, up from 11 in Q4 2020.
- Funds reported $1.45M of Alterity Therapeutics stock for Q1 2021, down 2.6% quarter-over-quarter.
- 2 funds opened new Alterity Therapeutics positions in Q1 2021 and 1 closed out, a net change of +1 holder.
- The largest Alterity Therapeutics buyer in Q1 2021 was Virtu Financial, an estimated $118K added.
- The largest Alterity Therapeutics seller in Q1 2021 was Sabby Management, an estimated $249K sold.
Based on aggregated 13F filings for Q1 2021.